These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 11868798
1. Spironolactone: is it a novel drug for the prevention of amphotericin B-related hypokalemia in cancer patients? Ural AU, Avcu F, Cetin T, Beyan C, Kaptan K, Nazaroglu NK, Yalcin A. Eur J Clin Pharmacol; 2002 Jan; 57(11):771-3. PubMed ID: 11868798 [Abstract] [Full Text] [Related]
3. Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: A retrospective analysis. Yamazaki H, Kondo T, Aoki K, Yamashita K, Takaori-Kondo A. Diagn Microbiol Infect Dis; 2018 Feb; 90(2):123-131. PubMed ID: 29203252 [Abstract] [Full Text] [Related]
4. Amiloride prevents amphotericin B related hypokalaemia in neutropenic patients. Smith SR, Galloway MJ, Reilly JT, Davies JM. J Clin Pathol; 1988 May; 41(5):494-7. PubMed ID: 3290263 [Abstract] [Full Text] [Related]
10. Association between potassium supplementation and the occurrence of acute kidney injury in patients with hypokalemia administered liposomal amphotericin B: a nationwide observational study. Ota Y, Obata Y, Takazono T, Tashiro M, Wakamura T, Takahashi A, Shiozawa Y, Miyazaki T, Nishino T, Izumikawa K. BMC Nephrol; 2021 Jun 30; 22(1):240. PubMed ID: 34193064 [Abstract] [Full Text] [Related]
12. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Prentice HG, Hann IM, Herbrecht R, Aoun M, Kvaloy S, Catovsky D, Pinkerton CR, Schey SA, Jacobs F, Oakhill A, Stevens RF, Darbyshire PJ, Gibson BE. Br J Haematol; 1997 Sep 30; 98(3):711-8. PubMed ID: 9332329 [Abstract] [Full Text] [Related]
13. Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia. Annino L, Chierichini A, Anaclerico B, Finolezzi E, Norata M, Cortese S, Cassetta MI, Fallani S, Novelli A, Girmenia C. Antimicrob Agents Chemother; 2013 Jun 30; 57(6):2596-602. PubMed ID: 23529741 [Abstract] [Full Text] [Related]
18. Continuous infusion of amphotericin B: preliminary experience at Faculdade de Medicina da Fundação ABC. Uehara RP, Sá VH, Koshimura ET, Prudente FV, Tucunduva LT, Gonçalves MS, Samano ES, del Giglio A. Sao Paulo Med J; 2005 Sep 01; 123(5):219-22. PubMed ID: 16358096 [Abstract] [Full Text] [Related]
20. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study. Chamilos G, Luna M, Lewis RE, Chemaly R, Raad II, Kontoyiannis DP. Clin Ther; 2007 Sep 01; 29(9):1980-6. PubMed ID: 18035197 [Abstract] [Full Text] [Related] Page: [Next] [New Search]